nightclaude · nightly deep dive · 2026-10-21

Amcor bought $23.51B in sales, now it must prove the cash

At $44.73, Amcor carries a $20.66B market cap on a $34.70B enterprise value for $23.51B of FY2026 revenue, up from $13.64B in FY2024 on SEC EDGAR facts. With $14.86B of total debt against $1.11B of cash, a 4.7% profit margin and 10.40 times forward earnings versus 18.79 times trailing, this is a Berry-built scale bet priced as a show-me deleveraging trade.

Packaging does not compound, it accumulates. Amcor, incorporated in 1926 and headquartered in Zurich, employs 75000 people selling films, bottles, closures and pharma devices direct to food and healthcare giants, and in FY2026 it printed $23.51B in revenue on SEC EDGAR facts versus $15.01B in FY2025 and $13.64B in FY2024. Unlike can pure plays Ball and Crown or fiber houses, Amcor chose to own every substrate at once, then super sized the bet until assets hit $37.09B and liabilities hit $25.29B.

At $44.73, between a $36.25 low and a $50.94 high, the market values that empire at $20.66B in equity and $34.70B in enterprise value, or 9.81 times EV to EBITDA with a 20.0% gross margin collapsing to a 4.7% profit margin. Operating cash flow was $2.15B against $922.00M of capex and $1.20B of dividends paid, with $14.86B of total debt against $1.11B of cash, so the only question that matters is whether volume plus procurement can turn bought scale into per share cash.

History & Ownership

Amcor plc was incorporated in 1926 and is headquartered in Zurich, Switzerland, an unusual domicile for a company that began life as Australian Paper Manufacturers. A century later it employs 75,000 people and, at $44.73 on October 20, 2026, carries a market capitalization of $20.66B and an enterprise value of $34.70B. That scale makes it the broad line generalist in consumer packaging, spanning flexible films and laminates plus rigid containers, closures and pharma delivery devices for nutrition, health, beauty and wellness, sold through a direct sales force across Europe, North America, Latin America and Asia Pacific.

From paper mill to serial acquirer

The origin story is consolidation, not invention. Australian Paper Manufacturers built a domestic paper and board franchise, rebranded as Amcor in the 1980s, then spent the 1990s and 2000s shedding paper to focus on packaging, including the PaperlinX demerger. The modern Amcor was forged by buying scaling packaging assets discarded by others, notably Alcan Packaging from Rio Tinto and, most importantly, Bemis in 2019, which created the dual NYSE and ASX listing and the Amcor plc structure that still trades today as AMCR.

Unlike Ball and Crown, which remain anchored in beverage and food cans, or Sealed Air, which remains anchored in protective films, Amcor chose breadth across substrates: polymer resin, aluminum and fiber based flexibles through its Global Flexible Packaging Solutions segment, and containers, closures and dispensing devices through Global Rigid Packaging Solutions. The logic is purchasing power in resin and film, shared innovation in barrier and sustainability, and a diversified customer book that neither pure play flexibles nor pure play rigids can match.

The Berry Global combination, completed effective April 30, 2025 (per amcor.com, April 30, 2025), is the largest expression of that playbook. The financial footprint in SEC EDGAR XBRL facts is abrupt. Revenue was $13.64B in FY2024 and $15.01B in FY2025, then $23.51B in FY2026. Total assets jumped from $16.52B in FY2024 to $37.07B in FY2025 and $37.09B in FY2026, while total liabilities moved from $12.57B to $25.33B to $25.29B over the same period. Stockholders equity moved from $3.88B to $11.73B to $11.79B, reflecting the all stock funding. Operating income, on the same XBRL basis, was $1.21B in FY2024, $1.01B in FY2025 and $1.90B in FY2026, with net income of $730.00M, then a loss of $39.00M in the deal year, then $1.11B in FY2026. Cash ended FY2026 at $1.11B versus $588.00M in FY2024.

Ownership and management character

Ownership is fully institutionalized with no founder block. Institutions hold 79.659% of shares across 999 holders, while insiders hold 0.254%, a classic widely held plc register. The register identified in mid 2026 reporting (per finance.yahoo.com, October 12, 2026) centers on index managers BlackRock and State Street plus active holders M&G, Invesco, Fuller and Thaler, Vanguard Capital Management and Geode, which explains the stock's index like behavior: a 1 year return of 16.4% to October 2026 against a 5 year return of negative 4.5%, trading between $36.25 and $50.94 over 52 weeks with a consensus buy and mean target of $49.76.

Management under Chief Executive Officer Peter Konieczny, cited in August 2026 company results coverage (per stockwatch.com, August 12, 2026), is operating as integrators rather than visionaries. The public message since the Berry close has been volume stabilization, pricing to cover unprecedented input cost inflation, and synergy realization running ahead of plan (per investing.com, September 10, 2026). Research and development expense of $170.00M in FY2026, up from $106.00M in FY2024 and $120.00M in FY2025 on an XBRL basis, points to where they claim differentiation will come from: material science for recyclable flexibles and pharma delivery, not mill capacity. With total debt at $14.86B against equity of $11.79B and free cash flow of $1.23B in FY2026 on a cash flow statement basis, or $1.50B on a trailing yfinance basis, the character test for the next two years is deleveraging and synergy conversion, not another transformative deal.

Business Model & Strategy

Amcor plc, incorporated in 1926 and headquartered in Zurich, Switzerland, is the world's largest diversified consumer packaging manufacturer by revenue, with $23.51B in FY2026 sales and 75000 employees across Europe, North America, Latin America and Asia Pacific. It sells directly, through its own sales force, to multinational food, beverage, healthcare, personal care and wellness brands for whom packaging is a non discretionary, high volume consumable. That customer structure, concentrated buyers purchasing billions of units, explains both the economics and the strategy: win the specification, run the plant hard, pass through resin and aluminum, and compound small per unit advantages at massive scale.

What it sells and to whom

Amcor develops and produces packaging for nutrition, health, beauty and wellness categories, a portfolio that spans films and laminates, bags and bulk bags, bottles and vials, jars, trays, tubs and pots, tubes, lids, closures, dispensing and pharma delivery devices, drinking cups, canisters and jerrycans, tapes and adhesives, plus wipes packaging and accessories. Materials span polymer resin, aluminum and fiber, which lets Amcor offer a customer plastic, paper or hybrid for the same end use. End markets are defensive by design: coffee, dairy, protein, pet food, medical, pharmaceutical and personal care, where volumes track consumption rather than durable goods cycles, and where qualification and food safety requirements create switching costs once Amcor is specified.

Two operating segments

Global Flexible Packaging Solutions develops and supplies flexible packaging, including polymer, aluminum and fiber based films and laminates. Global Rigid Packaging Solutions manufactures rigid containers, closures and specialty dispensing devices. Flexible is the innovation and sustainability engine, lightweighting, barrier, recycle ready and paper based structures. Rigid is the scale and tooling engine, high speed blow molding and injection with regional plant density. The FY2026 step change shows the combined weight of those engines after Berry:

Recurring, pass through revenue

Packaging is almost pure recurring revenue. Cups, pouches, lids, bottles and closures are consumed and reordered, with revenue growth of 25.9% in the pack year driven by acquired volume rather than one time equipment sales. Amcor operates on cost pass through for major inputs, which protects gross profit dollars at a 20.0% gross margin and 9.7% operating margin but compresses percentage margins when resin rises, the opposite of metal can peers that benefit from tighter tolling. The result is a volume plus productivity model: operating leverage comes from plant utilization, waste reduction and procurement, not price. That is why free cash flow of $1.50B, operating cash flow of $2.15B against capital expenditure of $922.00M, and a 9.4% ROE on $11.79B of equity matter more than headline sales.

Strategy and competitive flywheel

Strategy is scale, mix and synergy. Amcor buys regional leaders, Berry most recently, integrates procurement and back office, then cross sells the broader flexible plus rigid portfolio to shared global accounts. Fiscal 2026 was described as the first full year following the Berry acquisition, with the Berry business now largely integrated and $285 million in synergies from procurement, corporate functions and operational initiatives, about 10% ahead of expectations, toward a $650 million three year target (per sec.gov, September 2026). R and D, now $170.00M, is directed at the regulatory prize: recycle ready AmPrima and AmFiber paper, recycled content, and low carbon polyethylene developed with Dow to help brands cut Scope 3 emissions while holding barrier and line speed (per corporate.dow.com, September 2026). Against pure play flexible converters and rigid specialists, Amcor's flywheel is broader substrate choice, global qualification with one vendor, and synergy funded reinvestment, a moat built on procurement scale over $37.09B of assets and $14.86B of total debt rather than a single patent.

Segments & Products

Amcor at $44.73, a $20.66B market cap on a $34.70B enterprise value, is the consolidator in Packaging and Containers. FY2026 revenue was $23.51B, up from $15.01B in FY2025 and $13.64B in FY2024, with year over year revenue growth of 25.9%. That step change reflects the Berry combination, which management describes as now largely integrated with synergy capture running ahead of initial expectations (per packagingdive.com, August 2026). The commercial footprint is 75,000 employees selling direct across Europe, North America, Latin America and Asia Pacific.

Two reportable segments, one qualification moat

Global Flexible Packaging Solutions develops polymer resin, aluminum and fiber based flexible packaging: films and laminates, bags and bulk bags, wipes packaging, tapes and adhesives, tubes and applicators. Global Rigid Packaging Solutions manufactures rigid containers, closures, dispensing and pharma delivery devices: bottles and vials, jars, trays, tubs and pots, lids, canisters and jerrycans, drinking cups. The long tail covers apparel, building materials and accessories. Unlike pure flexible converters or pure rigid and closures specialists, Amcor bids for both sides of the bill of materials, which lets it follow large food, beverage, pharma and personal care buyers across substrates as they shift toward recycle ready and fiber based structures.

End markets served

Amcor frames its demand as nutrition, health, beauty and wellness, plus specialty applications. In practice that is packaged food, protein and dairy, coffee and nutrition powders, over the counter and prescription pharma, medical delivery, personal care and beauty, and industrial and building specialties. The cyclicality label of Consumer Cyclical understates the staples and regulated healthcare mix, where pack performance, barrier, sterility and dosing matter more than shelf pop. Sale is through a direct sales force, which in packaging means co development, line trials and multi year qualification, especially for pharma delivery devices, closures and dispensing systems where switching costs are highest. Volumes were described as inflecting to modestly positive in the June quarter with broad based improvement (per alphaspread.com, August 2026).

Pricing power

Pricing is cost plus with a lag, not cost plus with a guarantee. Resin and aluminum pass through protects gross profit dollars over time but compresses the gross margin rate when inputs spike, which is why the reported 20.0% gross margin, 9.7% operating margin and 4.7% profit margin matter more as a blend than in any single quarter. Power comes from mix and qualification: dispensing pumps, pharma delivery devices, high barrier laminates and beauty applicators carry engineering and regulatory friction that commodity canisters and jerrycans do not. Scale procurement across flexible and rigid, productivity from plant harmonization, and R and D of $170.00M in FY2026 versus $120.00M in FY2025 fund that migration. FY2026 operating income of $1.90B versus $1.01B in FY2025, on assets of $37.09B against liabilities of $25.29B and equity of $11.79B, shows operating leverage when volume stabilizes. Cash discipline is the backstop, with FY2026 operating cash flow of $2.15B, capital expenditure of $922.00M and free cash flow of $1.23B against cash dividends paid of $1.20B.

Growth drivers

• Combined wallet share: cross selling Berry rigid and dispensing with legacy flexible into shared food, health and beauty accounts, with private label and high growth categories prioritized for expansion.
• Health and delivery: pharma vials, closures and dispensing and delivery devices, where qualification locks in multi year volume and supports premium mix.
• Substrate shift: aluminum to high barrier polyolefin to fiber based flexible, plus lightweight rigid containers, sold as sustainability compliance rather than sustainability storytelling.
• Emerging market premiumization: Latin America and Asia Pacific demand for portion, reseal and shelf stable formats that raise units per dollar of food sold.

Operations & Go-to-Market

Amcor plc, incorporated in 1926 and headquartered in Zurich, Switzerland, is a scale manufacturer of consumer and healthcare packaging operating across Europe, North America, Latin America and the Asia Pacific with 75000 employees. The operating base that supports that reach carried $37.09B in total assets and $1.11B in cash and cash equivalents at June 30, 2026, against $23.51B in FY2026 revenue, up from $15.01B in FY2025 and $13.64B in FY2024 on a SEC EDGAR XBRL basis. That step change in balance sheet, from $16.52B in assets in FY2024 to $37.07B in FY2025 and $37.09B in FY2026, is the operational signature of the Berry Global combination, completed per amcor.com, April 2025, and now described as largely integrated per packagingdive.com, August 2026.

Footprint built for proximity

Packaging is a freight and service business, where plants must sit near food, beverage, pharmaceutical and personal care filling lines. Amcor runs that model at global scale, with two operating segments that together cover almost every rigid and flexible format a brand owner buys. The company funds the footprint with $2.15B in FY2026 operating cash flow against $922.00M in capital expenditure, and supports material science and line trials with $170.00M in FY2026 research and development expense, up from $106.00M in FY2024. Management discussion of synergy capture tracking ahead of initial expectations per packagingdive.com, August 2026, plus site rationalization and portfolio pruning themes discussed per packagingdive.com, February 2026 and May 2026, points to a post deal focus on density, utilization and mix rather than greenfield expansion.

What it makes and how integrated it is

Unlike pure converters that buy film and simply print and pouch it, Amcor retains resin, aluminum and fiber capability in flexibles and molding, closure and dispensing device capability in rigids, which lets it sell performance around barrier, shelf life, dosing and sustainability. That matters against can focused peers such as Ball and Crown, who dominate a single substrate, and against flexible peers such as Sealed Air and Huhtamaki, where breadth of substrates and health care qualification are differentiators.

How it sells and where it shows up

Amcor sells through its direct sales force, not distributors, which fits long qualification cycles in nutrition, health, beauty and wellness and multi year supply agreements with global CPG and pharma accounts. Geographic exposure is operationally diversified by design:

• Europe and North America: core profit pools for flexible food, protein, pet, medical and rigid beverage and home care, now broadened by Berry in containers and closures
• Latin America and Asia Pacific: volume growth and localization buffer, where local insight and expanded footprint are positioned as the ability to follow multinational customers wherever they operate per amcor.com
• End market posture: apparel, building materials and miscellaneous formats sit alongside regulated nutrition and health, smoothing cyclicality versus pure beverage or industrial exposure

The result is a $23.51B revenue machine that monetizes proximity, qualification and substrate optionality. Investors should judge go to market less on headline growth, which reflects the acquired asset base, and more on volume inflection, synergy realization and whether the direct sales organization converts broader products, services and innovation capabilities into retained share, as framed in FY2026 reporting per otcmarkets.com, August 2026.

Financials

Amcor’s FY2026, ended June 30, is a balance sheet transformation disguised as a growth year. Revenue was $23.51B in FY2026, up from $15.01B in FY2025, $13.64B in FY2024 and $14.69B in FY2023, with FY2022 at $14.54B (per EDGAR). Reported year over year growth was 25.9% (per yfinance). The jump reflects scale from acquisition, with the sales increase largely driven by the Berry Global acquisition and pass through of higher raw material costs, per finance.yahoo.com, August 2026. On a GAAP basis this is not cyclical volume recovery, it is a near doubling of the asset base to support that top line.

Margins, earnings and returns

Scale has not yet translated into margin expansion. Gross profit was $4.69B in FY2026 versus $2.83B in FY2025, $2.71B in FY2024 and $2.73B in FY2023 (per yfinance). That implies a 20.0% gross margin, with a 9.7% operating margin and 4.7% profit margin (per yfinance). Operating income on an XBRL basis was $1.90B in FY2026 versus $1.01B in FY2025, $1.21B in FY2024 and $1.51B in FY2023 (per EDGAR). EBITDA was $3.44B in FY2026 versus $1.77B in FY2025 and $1.85B in FY2024 (per yfinance). For a rigid and flexible packaging compounder that buys resin, aluminum and fiber and passes resin through with a lag, that mid teens EBITDA margin profile is the business model, not a temporary miss.

Net income was $1.11B in FY2026 versus a loss of $-39.00M in FY2025, $730.00M in FY2024 and $1.05B in FY2023, with FY2022 at $805.00M (per EDGAR). Diluted EPS was $2.38 in FY2026 versus $1.60 in FY2025, $2.52 in FY2024 and $3.52 in FY2023 (per yfinance). Management framed adjusted diluted EPS at $4.02 for FY2026, up 13% year over year, with Q4 at $1.23, per finance.yahoo.com, August 2026. Returns remain packaging like. ROE was 9.4% and ROA was 3.6% (per yfinance). R&D was $170.00M in FY2026 versus $120.00M in FY2025 and $106.00M in FY2024 (per EDGAR), immaterial against $23.51B of sales but directionally higher with the larger portfolio.

Balance sheet, cash flow and capital allocation

Total assets were $37.09B in FY2026 versus $37.07B in FY2025, $16.52B in FY2024 and $17.00B in FY2023 (per EDGAR). Total liabilities were $25.29B in FY2026 versus $25.33B in FY2025 and $12.57B in FY2024 (per EDGAR). Stockholders equity was $11.79B in FY2026 versus $11.73B in FY2025 and $3.88B in FY2024 (per EDGAR). Cash was $1.11B in FY2026 versus $827.00M in FY2025 and $588.00M in FY2024 (per EDGAR). Against that sits total debt of $14.86B in FY2026 versus $15.01B in FY2025 and $7.19B in FY2024, with long term debt of $13.86B in FY2026 versus $13.84B in FY2025 and $6.60B in FY2024 (per yfinance). Net debt was put at $12.90B with leverage at 3.5 times, per finance.yahoo.com, August 2026. At $44.73, with a $20.66B market capitalization and $34.70B enterprise value, the market prices a levered compounder at 18.79 times trailing earnings, 10.40 times forward earnings and 9.81 times EV to EBITDA, against a $49.76 mean target (per yfinance).

Cash conversion held up through the integration. Operating cash flow was $2.15B in FY2026 versus $1.39B in FY2025, $1.32B in FY2024 and $1.26B in FY2023 (per yfinance). Capital expenditure was $922.00M in FY2026 versus $580.00M in FY2025 and $492.00M in FY2024 (per yfinance). Free cash flow was $1.23B in FY2026 versus $810.00M in FY2025, $829.00M in FY2024 and $735.00M in FY2023 (per yfinance). Allocation favors the dividend over the buyback. Cash dividends paid were $1.20B in FY2026 versus $845.00M in FY2025, $722.00M in FY2024 and $723.00M in FY2023 (per yfinance). Repurchases were $72.00M in FY2026 versus $122.00M in FY2025, $81.00M in FY2024 and $653.00M in FY2023 (per yfinance). The thesis is deleveraging and synergy capture funding a payout that operating performance alone barely covers, which makes debt paydown, not multiple expansion, the swing factor.

Competitive Landscape & Moat

Amcor is scale packaging, not specialty packaging. After closing the all stock combination with Berry Global on April 30, 2025 (per prnewswire.com, November 2025), the company reports FY2026 revenue of $23.51B, up from $15.01B in FY2025, with total assets of $37.09B and 75000 employees. At $44.73, it carries a $20.66B market capitalization and a $34.70B enterprise value, trading at 18.79 times trailing earnings, 10.40 times forward earnings and 9.81 times EBITDA, with a consensus target of $49.76. The 1 year return is 16.4% against a 5 year return of negative 4.5%, with a 52 week range of $36.25 to $50.94. That is the setup: a newly bulked up leader still priced as a low growth compounder.

The field is fragmented, the customer is concentrated

Globally, packaging remains thousands of local plants selling to dozens of giant buyers in food, beverage, healthcare, and personal care. In North American flexible packaging, analysts frame the contest as Amcor, Sealed Air and ProAmpac competing on advanced film technology, sustainable design and speed to regulation (per mordorintelligence.com, September 2026). The named peer set is long: Sealed Air, Sonoco, Graphic Packaging, Mondi, Ball, Crown Holdings, Silgan Holdings, AptarGroup, Huhtamaki, Smurfit WestRock, Transcontinental and private Constantia Flexibles and Sigma Plastics Group. In rigid packaging specifically, Amcor led global sales in 2024 with only a 2% share (per einnews.com, July 2026), which tells you how little pricing power comes from share alone. The same report lists Ball, Crown, Silgan, Mondi, Sonoco, Sealed Air, Alpla, Ardagh and DS Smith as direct rigid competitors.

Where Berry changed the map

The Berry deal, described as a $8.4B combination creating roughly $23B in combined revenues across 400 facilities and 70,000 employees (per app.marginofinsight.com), made Amcor the self described largest flexible packaging company in the world. FY2026 results show why it mattered: full year net sales of $23.51B, up 57% largely driven by Berry, with adjusted EBITDA of $3,673 million, up 68% (per sec.gov, August 2026). Fourth quarter net sales were $6.4B, up 26% on Berry plus pass through of higher raw material costs, with adjusted EBITDA of $1,045 million, up 32%, and adjusted diluted EPS of $1.23, up 23% (per sec.gov, August 2026). Management disclosed $285 million in FY2026 synergies from procurement, corporate functions and operational initiatives, 10% ahead of expectation, including $115 million in the fourth quarter, toward a $650 million three year target (per sec.gov, September 2026 and nasdaq.com, August 2026).

Moat: switching costs plus procurement scale, not brand

Amcor has no consumer brand. Its moat is qualification and risk. Films and laminates, bottles and vials, lids, trays, tubes, closures and pharma delivery devices must be validated for barrier, sterility, shelf life and line speed. Once specified, a Nestle, PepsiCo or Pfizer does not switch to save a fraction of a cent. That shows up in the operating model: gross profit of $4.69B on a 20.0% gross margin, SEC operating income of $1.90B for a 9.7% operating margin, net income of $1.11B for a 4.7% profit margin, and return on equity of 9.4% on return on assets of 3.6%. Research and development of $170.00M in FY2026, up from $120.00M in FY2025, funds lightweighting, recyclable barrier and component reduction, the work that wins sustainability awards and helps customers manage extended producer responsibility fees for resin (per mordorintelligence.com, September 2026).

Scale is the second leg. With total debt of $14.86B, long term debt of $13.86B, cash of $1.11B and stockholders equity of $11.79B, Amcor buys resin, aluminum and board better than regional converters and spreads 400 plant overhead across $23.51B of volume. Operating cash flow was $2.15B, capital expenditure was $922.00M, free cash flow was $1.23B on a cash flow statement basis ($1.50B on a trailing yfinance basis), while cash dividends paid were $1.20B. The risk is that scale was bought with leverage, and pass through pricing means growth without margin expansion. If volumes stall at 0.5% organic growth as seen in the fourth quarter (per finance.yahoo.com, August 2026), Amcor must deliver the remaining synergy plan to justify 10.40 times forward earnings and close the gap to that $49.76 target.

Key Risks

• 1. Berry leverage leaves no margin for error: Total Debt $14.86B against Cash $1.11B and Equity $11.79B.
• 2. Thin, volatile conversion: 9.7% operating margin and 4.7% profit margin with Net Income swinging from $730.00M to $-39.00M to $1.11B.
• 3. Dividend versus deleveraging: $1.20B in Cash Dividends Paid consumed almost all $1.23B in Free Cash Flow.
• 4. Cyclical core masked by deal math: Revenue fell to $13.64B in FY2024 before jumping to $23.51B on Berry.
• 5. Perfection priced in: $44.73 pays 18.79 times trailing earnings for 10.40 times forward earnings.

1. The Berry balance sheet transformed Amcor into a leverage credit

Amcor ended FY2026 with Total Debt $14.86B, including Long Term Debt $13.86B, against Cash And Cash Equivalents $1.11B, StockholdersEquity $11.79B on Total Assets $37.09B, with Total Liabilities Net Minority Interest $25.29B. That scale did not exist two years earlier. XBRL Assets were $16.52B in FY2024 then $37.07B in FY2025, Liabilities $12.57B then $25.33B, Equity $3.88B then $11.73B, while RevenueFromContractWithCustomerExcludingAssessedTax jumped to $23.51B in FY2026 from $15.01B in FY2025 and $13.64B in FY2024. Enterprise Value $34.70B versus Market Cap $20.66B reflects net obligations trading as permanent capital. Recent commentary on the August 2026 results focused on Berry synergy capture against cash conversion (per investing.com, August 2026), and September conference commentary focused on the deleveraging path through portfolio reshaping (per investing.com, September 2026). Unlike flexible specialists or can makers that fund one substrate cycle, Amcor now must integrate flexible films, rigid containers, closures, dispensing and pharma devices across Europe, North America, Latin America and the Asia Pacific while servicing that debt.

What would confirm this risk: Total Debt remains near $14.86B while Cash stays near $1.11B and Total Liabilities Net Minority Interest fails to fall from $25.29B despite asset sales.

2. Profitability is thin and historically unstable

XBRL OperatingIncomeLoss was $1.90B on Revenue $23.51B in FY2026, consistent with the reported 9.7% operating margin, 20.0% gross margin and 4.7% profit margin, with ROA at 3.6% and ROE at 9.4%. EBITDA was $3.44B in FY2026 versus $1.77B in FY2025 and $1.85B in FY2024, and EV/EBITDA is 9.81, so the multiple already assumes the higher base holds. XBRL NetIncomeLoss was $1.05B in FY2023, $730.00M in FY2024, $-39.00M in FY2025 and $1.11B in FY2026, a full loss year followed by a record year on deal volume. ResearchAndDevelopmentExpense was only $170.00M in FY2026 versus $120.00M in FY2025, small for a nutrition, health, beauty and wellness supplier selling films and laminates, bottles and vials, jars, lids, trays, tubes and wipes packaging through a direct sales force where resin, aluminum and fiber pass through lags decide quarters. Competitors concentrated in single substrates can reprice faster, while Amcor absorbs mismatches across polymer, aluminum and fiber at once.

What would confirm this risk: OperatingIncomeLoss retreats toward the $1.01B reported in FY2025 while Revenue holds near $23.51B, proving pass through and mix did not stick.

3. The dividend competes directly with debt repayment

Operating Cash Flow was $2.15B in FY2026 and Capital Expenditure was $922.00M, leaving Free Cash Flow of $1.23B on the cash flow statement, $1.50B on the headline disclosure, against Cash Dividends Paid of $1.20B and Repurchase Of Capital Stock of only $72.00M. In FY2025 the same tension existed, with Operating Cash Flow $1.39B, Capital Expenditure $580.00M, Free Cash Flow $810.00M and Cash Dividends Paid $845.00M. Capex has stepped up with scale, from $526.00M in FY2023 to $492.00M in FY2024 to $580.00M in FY2025 to $922.00M in FY2026, to support 75000 employees and a global plant network. With Cash $1.11B versus Total Debt $14.86B, every dollar paid out is a dollar not used to cut the $13.86B of Long Term Debt.

What would confirm this risk: Cash Dividends Paid stays near $1.20B while Free Cash Flow stays near $1.23B and Total Debt stays near $14.86B, forcing Amcor to fund integration with new borrowing.

4. Organic demand is cyclical and already showed contraction

Before Berry, XBRL revenue was $14.54B in FY2022, $14.69B in FY2023, $13.64B in FY2024 and $15.01B in FY2025, so the core shrank then stagnated and the 25.9% revenue growth cited for FY2026 is acquisition arithmetic to $23.51B. The sector is Consumer Cyclical and the industry is Packaging and Containers, tied to packaged food, beverage, healthcare and personal care volumes that destock quickly. Price history reflects that skepticism, with last close $44.73 between the 52 week low $36.25 and high $50.94, a 1 year return of 16.4% but a 5 year return of negative 4.5%, and a 5 year range of $35.58 to $54.08. A 75000 person cost base built for $23.51B in sales deleverages fast if units slip 2 to 3 percent, the normal swing in consumer packaging.

What would confirm this risk: Revenue drifts back toward $15.01B on an organic basis while the 75000 employee base prevents OperatingIncomeLoss from holding near $1.90B.

5. The forward multiple demands flawless Berry execution

At $44.73, with Market Cap $20.66B, Amcor trades at Trailing P/E 18.79 but Forward P/E 10.40, so the market prices earnings almost doubling from the Diluted EPS of $2.38 reported in FY2026 versus $1.60 in FY2025. Analyst target mean $49.76 with a buy recommendation leaves only a modest gap to the $50.94 52 week high, and 999 institutions hold 0.79659 of shares with insiders at 0.00254, so positioning is crowded long. Net Income on a yfinance basis was $1.11B in FY2026 versus $511.00M in FY2025 and $730.00M in FY2024, and on an XBRL basis was $-39.00M in FY2025, meaning the E in P/E has not yet proven stable at this asset scale.

What would confirm this risk: Price falls from $44.73 toward $36.25 as Forward P/E 10.40 proves optimistic and Diluted EPS fails to hold above $2.38.

Lessons

Amcor at $44.73, with a $20.66B market cap and $34.70B enterprise value, is a textbook packaging compounder: 75,000 employees, two global segments, and a P and L that can double while shareholders tread water. The 1 year return is 16.4% but the 5 year return is still -4.5%.

1. Read the balance sheet before you celebrate the revenue jump

Per 10-K XBRL, revenue went from $13.64B in FY2024 to $23.51B in FY2026, with yfinance reporting 25.9% year over year growth. Assets went from $16.52B to $37.09B over the same period. The price was leverage: total debt went from $7.19B to $14.86B, long term debt from $6.60B to $13.86B, and total liabilities from $12.57B to $25.29B while equity finished FY2026 at $11.79B. Lesson: in roll up industries, sales growth without balance sheet growth is fiction, and balance sheet growth without deleveraging is just deferred risk.

2. In a 4.7% margin business, cash is truth and earnings are noise

Per 10-K XBRL, net income printed -$39.00M in FY2025 then $1.11B in FY2026, while operating income moved from $1.01B to $1.90B. Cash never lost the plot: operating cash flow was $1.39B in FY2025 and $2.15B in FY2026, funding $922.00M of capital expenditure and $1.20B of cash dividends paid in FY2026 for $1.23B of free cash flow. Lesson: underwrite low margin cyclicals on through cycle operating cash flow and dividend coverage, not on a single year of GAAP earnings.

3. 20.0% gross to 4.7% net leaves no room for sloppiness

Amcor discloses a 20.0% gross margin, a 9.7% operating margin and a 4.7% profit margin, with R and D of only $170.00M on $23.51B of FY2026 revenue. That funnel from gross to net, combined with $14.86B of total debt against $11.79B of equity and $1.11B of cash, explains a 9.4% ROE and 3.6% ROA. Flexible packaging funded by polymer resin, aluminum and fiber, and rigid containers and closures both live on volume, price pass through and plant utilization. Lesson: when conversion is this thin, pricing discipline and asset uptime are the entire investment thesis.

4. Boring gets a market multiple until it proves it can compound

Amcor trades at 18.79 times trailing earnings, 10.40 times forward earnings and 9.81 times EV to EBITDA, with a $49.76 mean target and a buy recommendation, stuck between a $36.25 52 week low and a $50.94 high and a $35.58 to $54.08 5 year range. Institutions hold 79.66% of shares and insiders hold 0.25%. Lesson: the market will pay a steady 9x to 10x EBITDA for defensive packaging cash flow, but it will not pay growth until debt falls and $1.50B of free cash flow converts into per share compounding rather than just covering the dividend.